Provider Portal
Request More Information
Order a Collection Kit

Healthcare Providers
Patients
OncoBEAM Technology
- Technology Overview
- Scientific Publications
Company
- About Sysmex Inostics
- In the News

Healthcare Providers
Patients
OncoBEAM Technology
- Technology Overview
- Scientific Publications
Company
- About Sysmex Inostics
- In the News

Order a Collection Kit
Request more information
Provider Portal

Featured news and press releases

The latest news on Sysmex Inostics and OncoBEAM™

Highlighting our company and offerings

As leaders in blood-based cancer testing, our technologies are often featured at conferences and journals across the globe. Here, you’ll find some of the latest news and feature articles about Sysmex Inostics and OncoBEAM™.

Archive

2018
2017
2016
2015
2014
2013

2018

Sysmex Inostics expands OncoBEAM™ liquid biopsy testing in the U.S. to assist clinicians and patients

Blood Profiling Atlas in Cancer Consortium (BloodPAC) Announces Milestone in Accelerating Development of Liquid Biopsy for Cancer: Initial Release of Open Data

Liquid Biopsy performance comparison of OncoBEAM™ RAS CRC and Idylla ctKRAS testing presented at ASCO GI 2018 meeting

Back to archive

2017

Expert Taskforce Recommendation of OncoBEAM™ RAS CRC Liquid Biopsy Testing in Routine Clinical Practice for Colorectal Cancer Patients

OncoBEAM™ EGFR Kit (RUO) at Jessenius Medical Faculty of Comenius University and its University Hospital, in Martin, Slovakia

Robust Performance of OncoBEAM™ RAS CRC Liquid Biopsy Testing in Routine Clinical Practice for Colorectal Cancer Patients Highlighted at ESMO 2017

The Clinical Value of Sysmex Inostics’ OncoBEAM™ RAS CRC Assay Highlighted in Back-to-Back Studies Published in the Annals of Oncology

Sysmex Inostics’ OncoBEAM™ Technology highlighted at ASCO 2017 Annual Meeting

Back to archive

2016

Sysmex Inostics blood-based RAS biomarker test now available in Italy

Sysmex Inostics announces the opening of its global training center for the OncoBEAM™ platform in Barcelona, Spain

Blood-based IVD RAS biomarker test now available in France

New liquid biopsy RAS testing for metastatic colorectal cancer patients now available for clinical practices

Blood-based RAS biomarker test now available in Slovakia

Sysmex signs supply and distribution agreement with Streck

Back to archive

2015

Blood-based RAS biomarker test now available in Germany

Sysmex Inostics’ expanded OncoBEAM™ RAS blood test demonstrated a high degree of concordance to tissue-based testing in a study presented at ESMO World GI

Sysmex and LabCorp Announce a Strategic Collaboration for Blood-Based Molecular Testing Services and Products to Support the Development of Precision Medicine in Oncology

Sysmex Inostics announces agreement with IndivuTest to offer Sysmex Inostics blood based mutation testing in Germany, Austria and Switzerland

Sysmex Inostics and Merck Serono announce first RAS testing center implementing Sysmex Inostics’ blood-based OncoBEAM™ testing in Spain: Important milestone for mCRC patients

Back to archive

2014

Sysmex Inostics GmbH to Collaborate with Merck KGaA

Back to archive

2013

Inostics’ blood test knows more

Inostics is part of a Personalized Medicine Initiative with Geisinger and Indivumed

Sysmex Inostics and Bayer HealthCare collaborate to develop blood-based companion diagnostic tests for targeted tumor therapies

Back to archive

Related sites

Sysmex Corporation
Sysmex Inostics
Sysmex Europe
Sysmex America

Our company

Contact us
Press releases
linkedin

Terms of Use
Online Privacy Policy
Notice of Privacy Practices -/ HIPAA Privacy Policy
Lab Certificates
Privacy Shield Privacy Policy

© 2018 Sysmex Inostics, Inc.